IL328906A - Chemical compounds and uses thereof - Google Patents
Chemical compounds and uses thereofInfo
- Publication number
- IL328906A IL328906A IL328906A IL32890626A IL328906A IL 328906 A IL328906 A IL 328906A IL 328906 A IL328906 A IL 328906A IL 32890626 A IL32890626 A IL 32890626A IL 328906 A IL328906 A IL 328906A
- Authority
- IL
- Israel
- Prior art keywords
- chemical compounds
- compounds
- chemical
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D261/00—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings
- C07D261/20—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings condensed with carbocyclic rings or ring systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202363611649P | 2023-12-18 | 2023-12-18 | |
| PCT/US2024/060009 WO2025136811A1 (en) | 2023-12-18 | 2024-12-13 | Chemical compounds and uses thereof |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IL328906A true IL328906A (en) | 2026-08-01 |
Family
ID=94341082
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL328906A IL328906A (en) | 2023-12-18 | 2024-12-13 | Chemical compounds and uses thereof |
Country Status (6)
| Country | Link |
|---|---|
| AR (1) | AR134697A1 (en) |
| AU (1) | AU2024408085A1 (en) |
| CO (1) | CO2026008873A2 (en) |
| IL (1) | IL328906A (en) |
| TW (1) | TW202542120A (en) |
| WO (1) | WO2025136811A1 (en) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2026128808A1 (en) | 2024-12-13 | 2026-06-18 | Ideaya Biosciences, Inc. | Kat6 and/or kat7 inhibitors for use in methods of treating cancer |
Family Cites Families (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB9624482D0 (en) | 1995-12-18 | 1997-01-15 | Zeneca Phaema S A | Chemical compounds |
| CA2242425C (en) | 1996-02-13 | 2006-07-18 | Zeneca Limited | Quinazoline derivatives as vegf inhibitors |
| NZ331191A (en) | 1996-03-05 | 2000-03-27 | Zeneca Ltd | 4-anilinoquinazoline derivatives and pharmaceutical compositions thereof |
| GB9718972D0 (en) | 1996-09-25 | 1997-11-12 | Zeneca Ltd | Chemical compounds |
| GB9714249D0 (en) | 1997-07-08 | 1997-09-10 | Angiogene Pharm Ltd | Vascular damaging agents |
| GB9900334D0 (en) | 1999-01-07 | 1999-02-24 | Angiogene Pharm Ltd | Tricylic vascular damaging agents |
| GB9900752D0 (en) | 1999-01-15 | 1999-03-03 | Angiogene Pharm Ltd | Benzimidazole vascular damaging agents |
| EE05345B1 (en) | 1999-02-10 | 2010-10-15 | Astrazeneca Ab | Quinazoline derivatives as inhibitors of angiogenesis |
| BR0111230A (en) | 2000-05-31 | 2003-06-10 | Astrazeneca Ab | Compound, and, use and process for the preparation thereof |
| UA73993C2 (en) | 2000-06-06 | 2005-10-17 | Астразенека Аб | Quinazoline derivatives for the treatment of tumours and a pharmaceutical composition |
| KR20030014425A (en) | 2000-07-07 | 2003-02-17 | 앤지오젠 파마슈티칼스 리미티드 | Colchinol derivatives as vascular damaging agents |
| EE200300015A (en) | 2000-07-07 | 2004-10-15 | Angiogene Pharmaceuticals Limited | Colchinol derivatives as inhibitors of angiogenesis |
| EP4385989A4 (en) * | 2021-08-10 | 2024-12-18 | Jiangsu Hengrui Pharmaceuticals Co., Ltd. | SULFONAMIDE DERIVATIVE, ITS PREPARATION PROCESS AND MEDICAL USE |
| WO2023114710A1 (en) * | 2021-12-13 | 2023-06-22 | Aurigene Oncology Limited | Fused benzoisoxazolyl compounds as kat6a inhibitors |
-
2024
- 2024-12-13 IL IL328906A patent/IL328906A/en unknown
- 2024-12-13 TW TW113148807A patent/TW202542120A/en unknown
- 2024-12-13 AU AU2024408085A patent/AU2024408085A1/en active Pending
- 2024-12-13 WO PCT/US2024/060009 patent/WO2025136811A1/en active Pending
- 2024-12-13 AR ARP240103473A patent/AR134697A1/en unknown
-
2026
- 2026-06-17 CO CONC2026/0008873A patent/CO2026008873A2/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| AU2024408085A1 (en) | 2026-06-18 |
| TW202542120A (en) | 2025-11-01 |
| CO2026008873A2 (en) | 2026-06-30 |
| AR134697A1 (en) | 2026-03-04 |
| WO2025136811A1 (en) | 2025-06-26 |